Hello, Fool! | Login | Signup | My Fool
Jul 19, 2008 10:47 AM ET | Site Changes | Help
Search: Tickers Company Names Players
The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies.
View All Commentary (BIIB)
Recs
biomimetic (34.96) Submitted: 3/17/08 5:01 PM : Start Price: $59.19 BIIB Score: 12.72
New drugs, better financial footing than competing drugs, rich pipeline, a multinational not weighed down as heavily by US moralizing issues
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK